Heart Failure News and Research

RSS

Heart failure (HF) is a condition in which a problem with the structure or function of the heart impairs its ability to supply sufficient blood flow to meet the body's needs. It should not be confused with cardiac arrest or myocardial infarction.

Oxford researchers find that pedalling may reduce performance in most people

Pedalling like Chris Froome or Alberto Contador might seem appealing, but Oxford University researchers have found that for most of us it's likely to reduce rather than improve our performance.

14 Sep 2015

UT Southwestern researchers part of study that shows effectiveness of intensive blood pressure management

More intensive management of high blood pressure, below a commonly recommended blood pressure target, significantly reduces rates of cardiovascular disease, and lowers risk of death in a group of adults 50 years and older with high blood pressure, a National Institutes of Health study involving UT Southwestern Medical Center researchers shows.

14 Sep 2015

Valtech receives CE Mark approval for Cardioband Mitral Reconstruction System

Valtech Cardio, Ltd.,, an innovator in the development of devices for mitral and tricuspid valve repair and replacement, announced today it has received Conformite Europeenne (CE) Marking for its Cardioband Mitral Reconstruction System (Cardioband), a proprietary, implantable mitral reconstruction device with a transfemoral, transseptal delivery system for mitral valve repair.

14 Sep 2015

Deadly parasite that causes Chagas disease widespread in Texas bugs

A deadly parasite that causes Chagas disease is widespread in a common Texas insect, according to a new study by University of Texas at El Paso researchers. The finding suggests that the risk of Texans contracting the disease may be higher than previously thought.

10 Sep 2015

Scientists identify new drug target to treat heart arrhythmias

Scientists at The Ohio State University Davis Heart and Lung Research Institute have identified a new target they hope will help make the next drug discovery for patients suffering from heart arrhythmias happen sooner.

9 Sep 2015

Simple test can lead to early detection of sleep apnea in hospitalized heart failure patients

Researchers at Thomas Jefferson University showed that a simple questionnaire, evaluation and pulse-oximetry monitoring can lead to early detection of sleep apnea in patients hospitalized for congestive heart failure (CHF).

9 Sep 2015

Thoratec begins SHIELD II U.S. clinical trial to examine use of HeartMate PHP in patients undergoing high-risk PCI

Thoratec Corporation, a world leader in mechanical circulatory support therapies to save, support and restore failing hearts, announced today that it has begun enrollment in the SHIELD II U.S. clinical trial examining the HeartMate PHP in patients undergoing a high-risk PCI (percutaneous coronary intervention) procedure.

4 Sep 2015

Depressive symptoms remain high in coastal areas affected by the Great East Japan Earthquake

A second round of aggregate findings from a study by Tohoku University's Tohoku Medical Megabank Organization (ToMMo) has revealed that depressive symptoms continue to be higher in coastal areas than in inland areas affected by the Great East Japan Earthquake and the tsunami that followed.

3 Sep 2015

Exercise training improves quality of life for patients with pulmonary hypertension

Exercise training for patients with pulmonary hypertension was shown to be safe and to improve quality of life, according to an analysis by UT Southwestern Medical Center cardiologists of studies involving more than 400 participants.

3 Sep 2015

New NIH grants support research that combines DNA sequence information and electronic medical records

A dozen awards from the National Institutes of Health will support research that incorporates DNA sequence information into electronic medical records. The goal of research conducted by the Electronic Medical Records and Genomics (eMERGE) network is to better understand the genomic basis of disease and to tailor medical care to individual patients based on their genomic differences.

2 Sep 2015

European cardiomyopathies registry shows higher than expected use of defibrillators, genetic testing

The most representative snapshot of real world practice in cardiomyopathies in Europe has shown a higher than expected use of defibrillators and genetic testing. The baseline results of the ESC's EORP Cardiomyopathy Registry Pilot are presented for the first time today at ESC Congress 2015.

2 Sep 2015

Finerenone drug improves albuminuria among patients with diabetes and kidney disease

Among patients with diabetes and kidney disease, most receiving an angiotensin-converting enzyme inhibitor or an angiotensin receptor blocker, the addition of the medication finerenone compared with placebo resulted in improvement in albuminuria (the presence of excessive protein [chiefly albumin] in the urine), according to a study in the September 1 issue of JAMA.

2 Sep 2015

HeartWare International signs definitive agreement to acquire Valtech

HeartWare International, Inc., a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure, announced today that it has entered into a definitive agreement to acquire Valtech Cardio, Ltd.

2 Sep 2015

Finerenone effective in heart failure patients with diabetes and/or chronic kidney disease

In heart failure patients with diabetes and/or chronic kidney disease, a new, non-steroidal mineralocorticoid receptor antagonist (MRA) called finerenone was no more effective than the currently approved MRA eplerenone in reducing the heart failure biomarker N-terminal pro-B-type natriuretic peptide [NT-proBNP].

1 Sep 2015

Defibrillator does not improve outcomes in patients with CRT pacemaker

Most patients with a cardiac resynchronisation therapy (CRT) pacemaker would not benefit from the addition of a defibrillator, according to results from the CeRtiTuDe cohort study presented for the first time today at ESC Congress1 and published in European Heart Journal.

1 Sep 2015

GARFIELD-AF Registry: All-cause death is most frequent major event in newly diagnosed AF patients

The first-ever two-year outcomes from the Global Anticoagulant Registry in the Field - Atrial Fibrillation (GARFIELD-AF) showcased at ESC Congress 2015 expose that all-cause death was the most frequent major event in more than 17,000 newly diagnosed AF patients, far exceeding the rate of stroke or major bleeding.

1 Sep 2015

Janssen, Bayer HealthCare announce results from landmark studies evaluating safety profile of XARELTO in NVAF patients

Janssen Pharmaceuticals, Inc., and its development partner, Bayer HealthCare, today announced results from PMSS (Post-Marketing Safety Surveillance) and XANTUS (XARELTO for Prevention of Stroke in Patients with Atrial Fibrillation), their landmark real-world studies evaluating the safety of XARELTO in people with non-valvular atrial fibrillation (NVAF).

1 Sep 2015

Two new pilot programs launched to reduce hospital readmissions, ease overcrowding in ERs and lower healthcare costs

The UCLA Center for Prehospital Care and collaborators from the Los Angeles County Emergency Medical Services (EMS) agency and the Glendale and Santa Monica fire departments are launching two pilot programs designed to reduce hospital readmissions, address overcrowding in emergency rooms, lower healthcare costs and boost patient satisfaction and quality of life.

1 Sep 2015

Pie Medical Imaging receives 2015 European Frost & Sullivan Award for Technology Leadership

Based on its recent analysis of the cardiovascular image management market, Frost & Sullivan recognizes Pie Medical Imaging (PMI) with the 2015 European Frost & Sullivan Award for Technology Leadership.

1 Sep 2015

ICDs with automated pulmonary congestion alert do not improve outcomes in heart failure patients

Heart failure patients whose implantable cardioverter defibrillators (ICDs) include an automated alert when too much fluid accumulates in their lungs did not have improved outcomes compared to patients with regular ICDs, according to results of the OPTILINK HF trial.

1 Sep 2015

Heart Failure News and Research

Further Reading

Oxford researchers find that pedalling may reduce performance in most people

UT Southwestern researchers part of study that shows effectiveness of intensive blood pressure management

Valtech receives CE Mark approval for Cardioband Mitral Reconstruction System

Deadly parasite that causes Chagas disease widespread in Texas bugs

Scientists identify new drug target to treat heart arrhythmias

Simple test can lead to early detection of sleep apnea in hospitalized heart failure patients

Thoratec begins SHIELD II U.S. clinical trial to examine use of HeartMate PHP in patients undergoing high-risk PCI

Depressive symptoms remain high in coastal areas affected by the Great East Japan Earthquake

Exercise training improves quality of life for patients with pulmonary hypertension

New NIH grants support research that combines DNA sequence information and electronic medical records

European cardiomyopathies registry shows higher than expected use of defibrillators, genetic testing

Finerenone drug improves albuminuria among patients with diabetes and kidney disease

HeartWare International signs definitive agreement to acquire Valtech

Finerenone effective in heart failure patients with diabetes and/or chronic kidney disease

Defibrillator does not improve outcomes in patients with CRT pacemaker

GARFIELD-AF Registry: All-cause death is most frequent major event in newly diagnosed AF patients

Janssen, Bayer HealthCare announce results from landmark studies evaluating safety profile of XARELTO in NVAF patients

Two new pilot programs launched to reduce hospital readmissions, ease overcrowding in ERs and lower healthcare costs

Pie Medical Imaging receives 2015 European Frost & Sullivan Award for Technology Leadership

ICDs with automated pulmonary congestion alert do not improve outcomes in heart failure patients

Industry Focus eBook - Cell biology (5th edition) eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News